About AN2 Therapeutics (ANTX)
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more
- USD1.04
- USD1.08
- USD1.03
- USD22.22
- -5.50%
- --
- 196.25k
- 192.38k
- 32M
- 0.87
- -92.70%
Stock News
yesterday
Constellation Brands CEO downplays worries about higher tariffs if Trump wins
CNBC
yesterday
Dow logs record high as stocks rise, Treasury yields jump after strong jobs data
MarketWatch
yesterday
East and Gulf Coast ports strike deal is not close to done: Automation still a big hurdle in ILA/USMX negotiations
CNBC
yesterday
Next steps for the Fed after strong jobs data — plus, news on health and beer stocks
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
